Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 3, 2009
- Revision received January 21, 2010
- Accepted January 22, 2010
- Published online March 23, 2010.
Copyright & Usage
Copyright© 2010 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- YOKO ISHIHARA1,
- KENICHI MATSUNAGA2,
- HIROKO IIJIMA2,
- GO HASEGAWA1,
- TOSHIMITSU SUZUKI3,
- ATSUSHI SATO4,
- TOMOWO KOBAYASHI5,
- MENG YANG6 and
- ROBERT M. HOFFMAN6,7
- 1Department of Public Health, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan
- 2Biomedical Research Laboratories, Kureha Corporation, Hyakunincho, Shinjuku, Tokyo 169-8503, Japan
- 3Department of Pathology, Fukushima Medical University School of Medicine, Hikarigaoka, Fukushima, Fukushima 960-1295, Japan
- 4Department of Medical Oncology, Showa University Hospital, Hatanodai, Shinagawa, Tokyo 142-8555, Japan
- 5Foundation for Drug Discovery, Pharma Valley Center, Hamamatsu, Shizuoka 430-8558, Japan
- 6AntiCancer Inc., San Diego, CA 92111, U.S.A.
- 7Department of Surgery, University of California, San Diego, CA 92103, U.S.A.
- Correspondence to: Yoko Ishihara, Department of Public Health, School of Medicine, Kurume University, Asahimachi, Kurume, Fukuoka 830-0011, Japan. e-mail: blackcat{at}med.kurume-u.ac.jp
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model
- Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model
- Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models